Latest Regulatory requirement Stories
HAYWARD, Calif., Jan. 26, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the U.S.
SAN DIEGO, Jan. 12, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
ERT’s Solutions Utilized in over Half of FDA Approvals PHILADELPHIA (PRWEB) January 08, 2015 ERT, a leading global solution provider for high-quality
- Trial results show novel S1P1 modulator produced strong, dose-dependent lymphocyte lowering - SAN DIEGO, Jan. 7, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
DALLAS, December 15, 2014 /PRNewswire/ -- According to the new research report "The Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals),
BIRMINGHAM, Ala., Dec.
Company Continues to Expect Clinical Trial Timelines to Remain Materially Unchanged and Expeditiously Resolved LOS ANGELES, Dec.
REDWOOD CITY, Calif., Dec. 2, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
LOS ANGELES, Dec.